Every ATOM vial ships with a per-lot Certificate of Analysis that documents exactly what's inside — including viability.
Three products. No bloated catalog, no confusing SKUs — cellular and acellular formats for licensed healthcare professionals.
Every ATOM MSC and ATOM MUSE order ships with a complimentary vial of ATOM X acellular secretome — at no additional cost. Two products in the box. One price.
Pricing, ordering, and full specifications unlock after provider verification — 24-hour turnaround.
One product, both routes. An umbilical cord–derived mesenchymal cellular product that a licensed provider may administer intravenously or by site-specific injection — no separate SKU to choose between. Released at 95% post-thaw viability and supplied with a per-lot Certificate of Analysis. Intended for provider-directed use within applicable law and the provider's scope of practice.
The most rigorously prepared format in the line. A specialized cellular subpopulation isolated through controlled environmental conditioning — mesenchymal cells taken through hypoxic, low-temperature selection so only the most resilient fraction endures, then expanded in suspension. Released at 95% post-thaw viability. Available by provider consultation, for IV or injection. Intended for provider-directed use within applicable law and the provider's scope of practice.
A concentrated acellular secretome — the naturally occurring signaling molecules, exosomes, and growth factors associated with cord-derived cells, isolated and packaged without live cells. The widest range of formats in the line: IV, injection, microneedling, and topical. Included free with every cell product, and available standalone. Supplied with a per-lot Certificate of Analysis. Intended for provider-directed use within applicable law and the provider's scope of practice.
A sterility panel is not a cell count. An ID screen is not a cell count. So here is ours — an actual live count of ATOM MUSE, on camera, showing the cells and the viability. Ask any supplier for the same thing.
Recorded demonstration of a cell count performed on ATOM MUSE (SSEC™). Results shown are for the lot demonstrated; every lot you receive is counted and documented on its own Certificate of Analysis.
Total cells per vial — the number your patient is effectively paying for, shown rather than asserted.
95% post-thaw viability — what percentage of those cells are alive after the vial comes out of the cold chain.
Both figures are verified independently by a third-party laboratory and printed on that lot's Certificate of Analysis.
Your patients are counting on your judgment — and your judgment is only as good as the product behind it. ATOM supplies a deliberately focused line of umbilical cord–derived cellular and acellular products, processed under cGMP-compliant, quality-controlled conditions at an FDA-registered laboratory. Our priority is transparent sourcing, rigorous third-party testing, and complete documentation, so the providers we work with know exactly what they are receiving.
Much of what cord-derived cells do, they do by communicating. Exosomes are the messengers — naturally occurring nano-scale extracellular vesicles that carry a cargo of proteins, growth factors, cytokines, mRNA, and microRNA between cells.
ATOM X isolates that signaling fraction and packages it without live cells — a concentrated secretome with a broader handling and storage profile than a cellular product. It is the most versatile format in the line: usable by IV, injection, microneedling, or topical application, and available both standalone and as a complimentary vial with every cell product.
Because the vesicle payload is delicate, how it is preserved matters as much as what is in it. Our process is designed to protect vesicle integrity through the cold chain, and every lot is characterized independently — so what is on the Certificate of Analysis is what is in the vial.
Six controlled stages from ethically sourced starting material to a vial at your clinic door — each one documented. Three stages, marked below, are where ATOM's quality is engineered.
Umbilical cord–derived starting material is ethically sourced from healthy, consenting donors at the time of birth — under strict maternal health screening and infectious disease testing before any material enters the workflow.
Rather than flat 2D plastic flasks, cells are transitioned into a 3D bioreactor suspension designed to more closely reflect the crowded, low-oxygen architecture of the body. The system is selected for its ability to support consistent, well-characterized conditions across the run — with results documented per lot rather than asserted.
For ATOM X, the extracellular vesicle fraction is isolated from the parent cells. Cellular debris is filtered out while the vesicle fraction is preserved within the target 30–150 nm size window.
Many conventional cryopreservation media rely on DMSO. ATOM products are preserved in a DMSO-Free Cryopreservation Solution instead — a chemically defined, cGMP-grade medium formulated to support lipid bilayer integrity and post-thaw recovery through the cold chain. No serum, no recombinant proteins, no animal-derived components.
No lot is released on our word alone. Every lot undergoes external validation through an independent third-party laboratory — covering post-thaw viability, particle characterization, sizing within the 30–150 nm window, and sterility. The results are documented on that lot's Certificate of Analysis.
Every vial ships overnight under a strict temperature-controlled cold chain. Your shipment arrives at your clinic door accompanied by its unique, lot-specific Certificate of Analysis and full chain of custody documentation — so you always know exactly what you received.
Processed at an FDA-registered, cGMP-compliant laboratory. Cryopreserved in a DMSO-Free Cryopreservation Solution — chemically defined, cGMP grade. Released at 95% post-thaw viability, documented on every lot's Certificate of Analysis.
Every ATOM product is processed at an FDA-registered laboratory under cGMP-compliant conditions, with rigorous donor screening and per-lot independent verification. Full documentation accompanies every shipment so providers know exactly what they are receiving.
Providers across a range of specialties incorporate regenerative medicine products into provider-directed protocols. The guide below maps ATOM formats to common practice settings — it describes product format, not a clinical indication or outcome.
Practices that commonly work with site-specific injectable formats and select IV protocols.
ATOM MSC · MUSEPractices that commonly work with injectable and acellular formats in provider-directed protocols.
ATOM MSC · XPractices that commonly work with systemic IV and acellular formats.
ATOM MSC · XPractices that work across the full range of cellular and acellular formats.
Full ATOM LineThe settings above describe the formats providers commonly select for their own protocols. They are not statements that any ATOM product diagnoses, treats, cures, mitigates, or prevents any disease or condition. Determination of appropriate use rests solely with the licensed provider, within their scope of practice and applicable law.
Answers to what licensed providers ask most about sourcing, documentation, and ordering.
ATOM products are supplied exclusively to licensed healthcare providers for provider-directed use within their scope of practice and applicable law. Provider licensure is verified before any pricing or commercial information is shared.
Yes. ATOM MSC is a single product supplied in one format that a licensed provider may administer intravenously or by site-specific injection — there is no separate IV and injection SKU. Determination of appropriate route and use rests solely with the provider, within their scope of practice and applicable law.
ATOM cell products are released at 95% post-thaw viability. Viability is measured per lot, and the result for the specific lot you receive is documented on that lot's Certificate of Analysis — not stated as a generic product specification.
Yes — we published one. Watch the live cell count of ATOM MUSE above. A sterility panel and an ID screen are real documents, but neither one is a cell count. We document the count and post-thaw viability for every lot on that lot's Certificate of Analysis.
ATOM products are processed at Regenerative Medicine Laboratory Solutions (RMLS Labs), an FDA-registered, cGMP-compliant laboratory in Madison, Wisconsin (FEI 3010691002), with rigorous donor screening, infectious disease testing, and per-lot independent verification. Tissue is ethically sourced from consenting donors at the time of birth.
No. ATOM products are not FDA-approved and are not FDA-cleared. The terms "FDA-registered facility" and "cGMP compliant" refer to facility registration and manufacturing practice standards only, and do not constitute FDA approval, clearance, or endorsement of any product. ATOM products are human cells, tissues, or cellular and tissue-based products (HCT/Ps).
Independent release testing is performed by an independent third-party laboratory. Results for each specific lot — not a generic specification — are documented on that lot's Certificate of Analysis.
Every unit ships with a per-lot Certificate of Analysis reflecting independent third-party test results, including post-thaw viability, along with chain of custody documentation. Orders ship overnight with cold chain packaging to preserve product integrity.
ATOM products are preserved in a chemically defined, DMSO-free, cGMP-grade cryopreservation solution. It is formulated to support cell recovery during storage and transport, with no serum, no recombinant proteins, and no animal-derived components.
Yes. Every ATOM MSC and ATOM MUSE (SSEC™) order ships with a complimentary vial of ATOM X acellular secretome at no additional cost. ATOM X is also available as a standalone product.
Pricing, ordering, and full product specifications are available to verified ATOM partners. Provider verification has a 24-hour turnaround, after which commercial information is unlocked.
Pricing, ordering, and full product specifications are available to verified ATOM partners. Get partner-level pricing, a dedicated rep, product education, and our done-for-you patient acquisition marketing — all in one application.
ATOM products are supplied exclusively to licensed healthcare professionals for provider-directed use within their scope of practice and applicable law. This page is intended for healthcare professionals and is not directed to consumers or patients.
ATOM products are not FDA-approved and are not FDA-cleared. "FDA-registered facility" and "cGMP compliant" refer to facility registration and manufacturing practice standards only, and do not constitute FDA approval, clearance, or endorsement of any product.
ATOM products are human cells, tissues, or cellular and tissue-based products (HCT/Ps). Providers are responsible for confirming the applicable regulatory status and requirements for any product before clinical use.
ATOM makes no representation that any product diagnoses, treats, cures, mitigates, or prevents any disease or condition, and guarantees no clinical outcome. Individual patient outcomes vary. Regenerative medicine is an emerging area of research.
Products are processed at Regenerative Medicine Laboratory Solutions (RMLS Labs), an FDA-registered laboratory in Madison, WI (FEI 3010691002). Independent third-party testing is performed by an independent laboratory. A lot-specific Certificate of Analysis accompanies every shipment.
Post-thaw viability of 95% reflects the release specification for ATOM cell products. Viability and other characterization results are measured per lot and reported on that lot's Certificate of Analysis rather than as a guarantee of any individual vial's performance.